To assist in quantitative bioanalysis, our chemical synthesis group can produce non-labeled or stable isotype-labeled compounds, such as deuterated or carbon-13 analogues, for use as internal standards. We can also assist with metabolite identification, profiling and synthesis.
Method Development and Transfer
Dedicated method development teams are able to rapidly evaluate and develop assays for you. Our firsthand knowledge in the development of a wide range of compounds and our experience across the drug development continuum can be used to help you create an efficient, cost-effective and successful program from discovery through the clinical phase. Our experts provide services for method transfer, development and validation in accordance with Good Laboratory Practices (GLP).